Protagenic Therapeutics executive chair Garo H. Armen acquires 20,000 common shares for $13,000
PTIX•Executive chair buys additional shares
- Garo H. Armen, executive chair and principal officer, bought 20,000 Protagenic Therapeutics common shares at $0.65 each.
- His directly held stake rose to 73,533 shares following the purchase.
